Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Weight loss jabs to have tougher checks
Prescriptions for weight loss drugs are skyrocketing, especially among young women. Experts think they know why.
The use of blockbuster weight loss drugs has surged among young women, for whom the treatments can often be "liberating."
Weight loss jabs to have tougher checks after people with eating disorders get prescriptions
Pharmacy regulator warns some people with history of eating disorders wrongly obtaining medicines such as Wegovy or Mounjaro
Pharmacies require stricter weight-loss jab checks
Online pharmacies will now have to employ stricter checks to stop people who are already a healthy weight or have a history of eating disorders buying weight-loss jabs. They will no longer be able to dispense the medication, sold under brand names such as Wegovy and Mounjaro, to patients who have just completed online questionnaires or sent photos.
Weight loss jabs: Patients in UK to face more stringent checks
People wanting to buy weight loss jabs online will face more stringent checks as part of a shake-up of UK pharmacy rules. The General Pharmaceutical Council (GPhC) has told online pharmacies they can no longer prescribe the drugs after reading a patient questionnaire,
What is Mounjaro and how does the weight-loss jab work? Pharmacies to face stricter checks for popular drug
What is Mounjaro and how does the weight-loss jab work? Pharmacies to face stricter checks for popular drug - Pharmacists who fail to adhere to the new guidelines could face fitness-to-practice invest
2d
on MSN
Here's why researchers think most people stop taking weight loss drugs within a year
Nearly 2 in 3 people without diabetes quit popular weight loss drugs such as Ozempic or Victoza within one year, according to ...
2d
How Weight-Loss Drugs Can Upend a Marriage
When Jeanne began to seriously consider taking Zepbound, one of the new-generation weight-loss drugs, she had the briefest of ...
Rolling Out
3d
The dark side of weight loss drugs no one warns about
New research uncovers hidden risks and surprising benefits of weight loss drugs like Ozempic, reshaping how we see these ...
13h
on MSN
Healthy Returns: Why people quit weight loss, diabetes drugs within one year
A new study examines how cost, side effects, and other factors influence whether people stop GLP-1s, while Noom cuts staff to ...
technologynetworks
2d
Weight Loss and Diabetes Drugs: What’s the Latest Research?
Drugs
like Ozempic® and Mounjaro® have become blockbuster
drugs
as of late, making headlines not only for their powerful
weight
loss
effects, but also for their potential to help other ...
Arizona Daily Star
5d
Ozempic vs. Semaglutide: 10 Weight Loss Medications Compared for 2025
Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ...
2d
on MSN
Forget Wegovy: Novo Nordisk May Have a New Billion-Dollar Weight Loss Drug On Its Hands
In fact, Novo Nordisk recently reported positive results for one of its anti-obesity candidates that puts its current ...
7d
on MSN
RFK Jr, Dr Oz and weight-loss drugs: A high-price health clash may be looming
Its weight-loss drug policy would fall to Trump's pick for health secretary, Robert F Kennedy Jr, and Mehmet Oz, Trump's ...
13d
on MSN
Massive study looks at benefits, risks of GLP-1 weight-loss drugs
As demand for weight-loss injections sold under brand names such as Ozempic and Wegovy continues to soar, a study has ...
4d
Half of Americans Support Weight-Loss Drugs Like Ozempic for Obesity, Poll
Cost is a major obstacle for many. The drugs can be expensive without insurance, with out-of-pocket expenses reaching ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Related topics
Novo Nordisk
Josh Gad
Metsera
Fortune Media IP
General Pharmaceutical Council
Feedback